Preparation method and intermediate of fenerenone
By reacting the compound of Formula 6 with an activator and an amination agent to produce a fenelone, the problems of long reaction routes, low resolution yields and many decarboxylation by-products in the prior art are solved, and high yields and high purity are achieved Fenelone preparation reduces production costs and is suitable for industrial production.
Patent Information
- Application Number
- CN202410982884.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-22
- Publication Date
- 2024-11-22
AI Technical Summary
The existing methods of preparation of fonelone have problems such as long reaction routes, low split yields, many decarboxylation by-products and high production costs, resulting in low product purity and total yields, making it difficult to be suitable for large-scale industrial production.
Using a new preparation method, the compound of formula 6 is reacted with an activator to form an active intermediate, and reacted with an amination agent in the presence of Lewis acid or base to produce a fenellone, thereby avoiding decarboxylation during hydrolysis. Product generation simplifies process steps and improves product purity and yield.
The high yield and high purity preparation of non-nelinone is achieved, the process steps are simplified, the production costs are reduced, and the generation of decarboxylation by-products is avoided, making it suitable for industrial large-scale production.
Smart Images

Figure CN118994148A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of organic compound synthesis, in particular to a preparation method and an intermediate of finerenone. Background Art
[0002] Finerenone (English name: Finerenone), a non-steroidal selective mineralocorticoid receptor antagonist developed by Bayer, can be used to prevent and / or treat cardiovascular and kidney diseases such as heart failure and diabetic nephropathy. Its chemical name is (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide. In July 2021, finerenone was approved for marketing by the US FDA in 10mg and 20mg specifications, respectively, for the treatment of adult patients with chronic kidney disease (stages 3 and 4 with albuminuria) and type 2 diabetes.
[0003] The structure of finerenone is shown below:
[0004]
[0005] The preparation methods of phenerenone disclosed in the prior art mainly include the following:
[0006] Prior art CN101641352A discloses a route 1 for synthesizing finerenone, which uses 2-methoxy-4-cyanobenzaldehyde as a raw material, and condenses it with 2-cyanoethyl-3-oxobutyrate to obtain an intermediate compound of formula 3, which is then condensed with 4-amino-5-methylpyridin-2(1H)-one (compound of formula 9) to obtain an intermediate compound of formula 4, which is ethylated with triethyl orthoformate to obtain an intermediate compound of formula 5, which is hydrolyzed and aminated to obtain an intermediate compound of formula 7, and the compound of formula 7 is subjected to chiral resolution to obtain finerenone. The reaction formula of this route is as follows:
[0007]
[0008]
[0009] The process of route 1 mainly has the following problems: ① 2-cyanoethyl-3-oxobutyrate is scarce and expensive; ② the reaction route is long; ③ the ester group needs to be hydrolyzed into carboxylic acid first and then activated by amination, and the hydrolysis needs to be carried out in the presence of a strong base. After the reaction, it needs to be adjusted to acidity with acid. The compound of formula 6 containing carboxylic acid is easy to produce decarboxylation byproducts under this condition:
[0010] The crude product of the compound of formula 6 containing the decarboxylation byproduct is directly subjected to amination, and the obtained finerenone contains a high content of the decarboxylation byproduct and needs to be further purified (see Figure 1 ). ④ The yield of the splitting step is lower than 45%, resulting in a low total yield. In addition, the splitting step causes a large loss after obtaining the racemate of finerenone, resulting in a high production cost, and is not suitable for large-scale industrial production.
[0011] Prior art CN116496273A discloses a route 2 for synthesizing finerenone, which uses 2-methoxy-4-cyanobenzaldehyde as a raw material, which is subjected to a condensation reaction with allyl acetoacetate to obtain an intermediate compound of formula 3, which is subjected to a condensation reaction with 4-amino-5-methylpyridin-2(1H)-one (compound of formula 9) to obtain an intermediate compound of formula 4, which is ethylated with triethyl orthoformate to obtain an intermediate compound of formula 5, which is subjected to chiral resolution to obtain a chiral intermediate compound of formula 6, which is hydrolyzed and aminated to obtain finerenone.
[0012]
[0013] In route 2, the finerenone intermediate compound of formula 5 is first subjected to chiral resolution, and then hydrolyzed and aminated to obtain the finerenone bulk drug. Although the purity of the intermediate compound of formula 6 obtained by this route is relatively ideal, there are still similar problems as the above route: ① The reaction route is long, and the yield of the resolution step is less than 40%, and the total yield is not high; ② Decarboxylation by-products are present during the hydrolysis of the compound of formula 6. The crude compound of formula 6 containing the decarboxylation by-product is directly aminated, and the obtained finerenone contains a high content of the decarboxylation by-product, which needs to be further purified (see Figure 2 ). In addition, this route requires the use of expensive palladium catalysts in the amination process, resulting in high production costs and the presence of heavy metal residues.
[0014] Prior art CN116891471A discloses route 3 for synthesizing finerenone. This route uses 3-bromo-4-methoxybenzaldehyde as a raw material, which is subjected to a condensation reaction with methyl acetoacetate to obtain an intermediate compound of formula 3, which is then condensed with 4-amino-5-methylpyridin-2(1H)-one (compound of formula 9) to obtain an intermediate compound of formula 4, which is ethylated with triethyl orthoformate to obtain an intermediate compound of formula 5, which is subjected to chiral resolution with a resolving agent to obtain a chiral intermediate compound of formula 6, which is then subjected to cyanidation, hydrolysis, and amination to obtain the finerenone API.
[0015]
[0016]
[0017] Although the purity and separation yield of the intermediate obtained in route 3 are relatively ideal, there are still similar problems as in the above route: ① the reaction route is too long, resulting in a low total yield; ② decarboxylation byproducts are present during the hydrolysis of the compound of formula 7, and the crude compound of formula 7 containing the decarboxylation byproducts is directly aminized, and the obtained finerenone contains a high content of the decarboxylation byproducts, which needs to be further purified (see Figure 3 In addition, this route requires potassium ferrocyanide catalyst to obtain carboxylic acid, followed by amidation. Potassium ferrocyanide catalyst is expensive, resulting in high commercial production costs.
[0018] Prior art CN115340539A discloses a method for preparing finerenone and its intermediates, route 4, which uses 2-methoxy-4-cyanobenzaldehyde as a raw material, which is subjected to a condensation reaction with benzyl acetoacetate to obtain an intermediate compound of formula 2, which is subjected to a condensation reaction with 4-amino-5-methylpyridin-2(1H)-one to obtain an intermediate compound of formula 3, which is ethylated with triethyl orthoformate to obtain an intermediate compound of formula II, which is subjected to chiral resolution to obtain a chiral intermediate compound of formula I, which is debenzylated to form a carboxylic acid-containing compound I-1, which is then aminated to obtain finerenone.
[0019]
[0020] Although the purity and resolution yield of the intermediate obtained in route 4 are relatively ideal, especially the resolution effect of the compound of formula II is very good, there are still problems similar to the original research process: ① The reaction route is relatively long; ② The compound I-1 containing carboxylic acid will form a decarboxylation by-product. The crude compound of formula I-1 containing the decarboxylation by-product is directly aminized, and the obtained finerenone contains a high content of the decarboxylation by-product and needs to be further purified (see Figure 4 ).
[0021] For industrial scale-up, the obvious decarboxylation byproducts bring great economic and time costs to the subsequent treatment. Therefore, it is urgent to establish a preparation method of phenerenone with easy-to-obtain raw materials, high yield, high product purity and easy purification. Summary of the invention
[0022] In order to solve the problems existing in the preparation method of finerenone in the prior art, the purpose of the present invention is to provide a new preparation method of finerenone, which has a short preparation route, no decarboxylation product, high purity of the final product, and is easy to purify.
[0023] In a first aspect of the present invention, there is provided a method for preparing finerenone, comprising the following steps:
[0024] (a) reacting a compound of formula 6 with an activating agent until compound 6 is completely converted into an active intermediate;
[0025] (b) adding an aminating agent to the reaction solution of step (a), wherein the active intermediate reacts with the aminating agent to generate finerenone,
[0026] The reaction formula is as follows:
[0027]
[0028] The activator is selected from dichlorodiphenylmethane, thionyl chloride (SOCl2), oxalyl chloride ((COCl)2), cyanuric chloride (TCT), phosphoryl chloride (POCl3), phosphorus trichloride (PCl3), phosphorus pentachloride (PCl5), or a combination thereof,
[0029] The aminating agent is selected from ammonia gas, ammonia water, an organic solution containing ammonia gas or hexamethyldisilazane.
[0030] In another preferred embodiment, the reaction of the compound of formula 6 with the activator in step (a) is carried out in the presence of a Lewis acid. In another preferred embodiment, the Lewis acid is selected from BiCl2, TiCl4, SnCl2, AlCl3, CuCl2, MnCl2, CuI, CuBr or a combination thereof. In another more preferred embodiment, the Lewis acid is selected from SnCl2 or BiCl2.
[0031] In another preferred embodiment, the reaction of the active intermediate with the aminating agent in step (b) is carried out in the presence of a base. In another preferred embodiment, the base is selected from triethylamine, N,N-diisopropylethylamine, pyridine, N-methylmorpholine, or a combination thereof. In another more preferred embodiment, the base is selected from N,N-diisopropylethylamine.
[0032] In another more preferred embodiment, the activator is selected from dichlorodiphenylmethane.
[0033] In another more preferred embodiment, the aminating agent is selected from ammonia gas, ammonia water or an organic solution containing ammonia gas.
[0034] In another more preferred embodiment, the aminating agent is selected from ammonia.
[0035] In another preferred embodiment, in steps (a) and (b), the solvent used in the reaction is selected from dichloroethane, 1,4-dioxane, tetrahydrofuran, acetonitrile, toluene, trifluorotoluene, dichloromethane, or a combination thereof. More preferably, dichloroethane.
[0036] In another preferred embodiment, in step (a), the molar ratio of the compound of formula 6 to the Lewis acid is 1:0.01-1, more preferably, 1:0.02-0.5.
[0037] In another preferred embodiment, in step (a), the molar ratio of the compound of formula 6 to the activator is 1:1.0-3.0, more preferably, 1:1.1-1.6.
[0038] In another preferred embodiment, in step (b), the aminating agent is selected from ammonia, and the amination reaction is carried out in a nitrogen atmosphere of 0.1 to 1.0 MPa. In another preferred embodiment, in step (b), the aminating agent is selected from ammonia water, an organic solution containing ammonia, and the molar ratio of the aminating agent to the compound of formula 6 is 1:2 to 50, preferably 1:10 to 30. In another preferred embodiment, in step (b), the aminating agent is selected from hexamethyldisilazane, and the molar ratio of the compound of formula 6 to the aminating agent is 1:1 to 5, preferably 1:2 to 3.
[0039] In another preferred embodiment, in step (b), the molar ratio of the compound of formula 6 to the base is 1:1.0-5.0, more preferably, 1:1.2-2.5.
[0040] In another preferred embodiment, the reaction temperatures of step (a) and step (b) are both 0-40°C, more preferably, 15-30°C.
[0041] In another preferred embodiment, in the above-mentioned method for preparing finerenone, the method for preparing the compound of formula 6 comprises the following steps:
[0042] The compound of formula 5 is mixed with a resolving agent, subjected to a salt-forming reaction, separated to obtain a salt, and the salt is treated with a base to obtain a compound of formula 6, and the reaction formula is as follows:
[0043]
[0044] In another preferred embodiment, the resolving agent is selected from L-tartaric acid, L-dibenzoyltartaric acid, L-di-p-methylbenzoyltartaric acid, L-di-p-methoxybenzoyltartaric acid, L-di-p-methylbenzoyltartaric acid, L-di-p-nitrobenzoyltartaric acid, L-di-p-chlorobenzoyltartaric acid, L-di-p-cyanobenzoyltartaric acid, or a combination thereof. In another more preferred embodiment, the resolving agent is selected from L-dibenzoyltartaric acid and L-di-p-methylbenzoyltartaric acid.
[0045] In another preferred embodiment, the base is selected from sodium hydroxide, potassium hydroxide, sodium carbonate, sodium bicarbonate, potassium carbonate, sodium phosphate, potassium phosphate, or a combination thereof. In another more preferred embodiment, the base is selected from sodium bicarbonate and sodium phosphate.
[0046] In another preferred embodiment, the salt-forming reaction is carried out in a solvent, and the solvent is selected from water, methanol, ethanol, isopropanol, n-butanol, sec-butanol, ethylene glycol dimethyl ether, acetone, ethyl acetate, or a combination thereof, more preferably methanol.
[0047] In another preferred embodiment, the reaction temperature of the salt-forming reaction is 50-80°C, more preferably 55-70°C.
[0048] In another preferred embodiment, the molar ratio of the compound of formula 5 to the resolving agent is 1:0.4-1.5, more preferably 1:0.4-1.3, and most preferably 1:0.5-0.8.
[0049] In another preferred embodiment, the amount of the base used is such that the pH of the system is 8-9.
[0050] In another preferred embodiment, in the above-mentioned method for preparing finerenone, the method for preparing the compound of formula 5 comprises the following steps:
[0051] In the presence of an acid, the compound of formula 4 reacts with triethyl orthoformate to generate a compound of formula 5. The reaction formula is as follows:
[0052]
[0053] In another preferred embodiment, the acid is selected from sulfuric acid, hydrochloric acid, nitric acid, phosphoric acid, or a combination thereof, more preferably sulfuric acid or hydrochloric acid.
[0054] In another preferred embodiment, the molar ratio of the compound of formula 4 to the acid is 1:0.01 to 1:0.5, more preferably, 1:0.05 to 1:0.2.
[0055] In another preferred embodiment, in the method for preparing the compound of formula 5, the molar ratio of the compound of formula 4 to triethyl orthoformate is 1:1-5, more preferably, 1:1.5-2.6.
[0056] In another preferred embodiment, in the method for preparing the compound of formula 5, the reaction temperature is 80°C to 150°C; more preferably, 90°C to 140°C.
[0057] In another preferred embodiment, in the preparation method of the compound of formula 5, the solvent used is selected from N,N-dimethylacetamide, N,N-dimethylformamide, N-methylpyrrolidone, or a combination thereof, more preferably, N,N-dimethylformamide or N,N-dimethylacetamide.
[0058] In another preferred embodiment, in the above-mentioned method for preparing finerenone, the method for preparing the compound of formula 4 comprises the following steps:
[0059] (1) a compound of formula 2 is subjected to a condensation reaction with a compound of formula 7 to produce a mixture of a compound of formula 3 and a compound of formula 3';
[0060] (2) a mixture of the compound of formula 3 and the compound of formula 3' is subjected to a condensation reaction with the compound of formula 8 to generate a compound of formula 4,
[0061] The reaction formula is as follows:
[0062]
[0063] In another preferred embodiment, a base catalyst and an acid are also present in the reaction system of step (1). In another preferred embodiment, the base catalyst is selected from piperidine, morpholine, piperazine, tetrahydropyrrole, or a combination thereof, more preferably piperidine. The acid is selected from acetic acid, sulfinic acid, formic acid, butyric acid, oxalic acid, or a combination thereof, more preferably acetic acid or acetic acid.
[0064] In another preferred embodiment, in step (1), the temperature for the condensation reaction of the compound of formula 2 and the compound of formula 7 is 20°C to 50°C, more preferably, 30°C to 45°C.
[0065] In another preferred embodiment, in the reaction system of step (1), the molar ratio of the compound of formula 2: the compound of formula 7: the base catalyst: the acid is 1:1.1-3.0:0.01-0.5:0.01-0.5, more preferably 1:1.2-2.0:0.05-0.2:0.05-0.2.
[0066] In another preferred embodiment, in step (1), the solvent used for the condensation reaction of the compound of formula 2 and the compound of formula 7 is selected from dichloromethane, sec-butanol, n-butanol, isopropanol, methanol, ethanol, or a combination thereof, more preferably isopropanol.
[0067] In another preferred embodiment, the reaction temperature of step (2) is 50°C to 120°C, more preferably 60°C to 80°C.
[0068] In another preferred embodiment, in step (2), the molar ratio of the mixture of the compound of formula 3 and the compound of formula 3' to the compound of formula 8 is 1:1-3, more preferably 1:1.2-1.5.
[0069] In another preferred embodiment, the solvent used in step (2) is selected from n-butanol, isopropanol, methanol, ethanol, sec-butanol, or a combination thereof, more preferably, methanol or ethanol.
[0070] In another preferred embodiment, the preparation method of finerenone provided by the present invention comprises the following steps:
[0071] (1) a compound of formula 2 is subjected to a condensation reaction with a compound of formula 7 to produce a mixture of a compound of formula 3 and a compound of formula 3';
[0072] (2) a mixture of the compound of formula 3 and the compound of formula 3' is subjected to a condensation reaction with the compound of formula 8 to generate a compound of formula 4,
[0073] (3) In the presence of an acid, the compound of formula 4 reacts with triethyl orthoformate to produce a compound of formula 5,
[0074] (4) the compound of formula 5 is mixed with a resolving agent, subjected to a salt-forming reaction, separated to obtain a salt, and the salt is treated with a base to obtain a compound of formula 6,
[0075] Wherein, the resolving agent is selected from L-tartaric acid, L-dibenzoyltartaric acid, L-di-p-methylbenzoyltartaric acid, L-di-p-methoxybenzoyltartaric acid, L-dibenzoyltartaric acid, L-di-p-methoxybenzoyltartaric acid, L-di-p-methylbenzoyltartaric acid, L-di-p-nitrobenzoyltartaric acid, L-di-p-chlorobenzoyltartaric acid, L-di-p-cyanobenzoyltartaric acid, or a combination thereof,
[0076] (5) The compound of formula 6 is first reacted with an activating agent until the compound 6 is completely converted into an active intermediate, and an aminating agent is added to the reaction solution to allow the active intermediate to react with the aminating agent to generate finerenone.
[0077] Wherein, the activator is selected from dichlorodiphenylmethane, thionyl chloride, oxalyl chloride, cyanuric chloride, chlorophosphoryl, phosphorus trichloride, phosphorus pentachloride, or a combination thereof, and
[0078] Wherein, the aminating agent is selected from ammonia gas, ammonia water, an organic solution containing ammonia gas, hexamethyldisilazane
[0079] The reaction formula is as follows:
[0080]
[0081] In a second aspect of the present invention, there is provided a method for preparing a compound of formula 4, comprising the following steps:
[0082]
[0083] In the third aspect of the present invention, there is provided a method for preparing a compound of formula 5, comprising the following steps:
[0084] (3-1) providing a compound of formula 4,
[0085] (3-2) In the presence of an acid, the compound of formula 4 reacts with triethyl orthoformate to generate a compound of formula 5,
[0086] The reaction formula is as follows:
[0087]
[0088] In another preferred embodiment, the compound of formula 4 is obtained according to the above-mentioned preparation method.
[0089] In a fourth aspect of the present invention, there is provided a method for preparing a compound of formula 6, comprising the following steps:
[0090] (4-1) providing a compound of formula 5,
[0091] The compound of formula (4-2) 5 is mixed with a resolving agent, subjected to a salt-forming reaction, separated to obtain a salt, and the salt is treated with a base to obtain
[0092] The compound of formula 6 has the following reaction formula:
[0093]
[0094] In another preferred embodiment, the resolving agent is selected from L-tartaric acid, L-dibenzoyltartaric acid, L-di-p-methylbenzoyltartaric acid, L-di-p-methoxybenzoyltartaric acid, L-dibenzoyltartaric acid, L-di-p-methoxybenzoyltartaric acid, L-di-p-methylbenzoyltartaric acid, L-di-p-nitrobenzoyltartaric acid, L-di-p-chlorobenzoyltartaric acid, L-di-p-cyanobenzoyltartaric acid, or a combination thereof, more preferably L-dibenzoyltartaric acid and L-di-p-methylbenzoyltartaric acid.
[0095] In another preferred embodiment, the compound of formula 5 is obtained according to the above-mentioned preparation method.
[0096] In a fifth aspect of the present invention, a compound or a salt thereof is provided, the structure of the compound is shown below:
[0097] BRIEF DESCRIPTION OF THE DRAWINGS
[0098] Figure 1 According to the route of the prior art CN101641352A, the reaction solution obtained by hydrolyzing the compound of formula 5 is treated to obtain a crude compound of formula 6, and the crude product is aminated to obtain the LC / MS spectrum of the crude finerenone, wherein peak 8 (RT = 15.927min, m / z = 336.17 [M+H] + ) is a byproduct of decarboxylation.
[0099] Figure 2 According to the route of the prior art CN116496273A, the reaction solution obtained by hydrolyzing the compound of formula 6 is treated to obtain a crude product of the compound of formula 7, and the crude product is aminated to obtain the HPLC spectrum of the crude finerenone, wherein the 30# peak (RT=16.213min) is a decarboxylation byproduct.
[0100] Figure 3 According to the route of the prior art CN116891471A, the reaction solution obtained by hydrolyzing the compound of formula 7 is treated to obtain a crude product of the compound of formula 8, and the crude product is aminated to obtain the LC / MS spectrum of the crude product of finerenone, wherein peak 11 (RT = 15.885min, m / z = 336.17 [M+H] + ) is a byproduct of decarboxylation.
[0101] Figure 4According to the route of the prior art CN115340539A, the compound of formula I is debenzylated to obtain a crude product of the compound of formula I-1 containing a carboxyl group, and the crude product is aminated to obtain the HPLC spectrum of the crude product of finerenone, wherein the 23# peak (RT=16.240min) is the decarboxylation byproduct. The content of the decarboxylation byproduct is significantly higher than that of the Figure 1 , 2 And the content in 3 is small.
[0102] Figure 5 This is the HPLC spectrum of finerenone obtained by treating the reaction solution in Example 5-1 of the present application, wherein peak 13# (RT=16.215 min) is a decarboxylation byproduct, and its content is relatively low, only 0.168%.
[0103] Figure 6 This is the HPLC spectrum of the finerenone obtained by treating the reaction solution in Example 5-1 of the present application, and the product after further purification does not contain decarboxylation byproducts.
[0104] Figure 7 This is the HPLC spectrum of finerenone obtained by treating the reaction solution in Example 5-2 of the present application, which does not contain decarboxylation byproducts.
[0105] Figure 8 The reaction mechanism of the compound of formula 6 to generate amide under the action of SnCl2, dichlorodiphenylmethane and an aminating agent is shown. DETAILED DESCRIPTION
[0106] In view of the defects existing in the preparation process of finerenone in the prior art, especially the problem of generating a large number of decarboxylation byproducts, the inventors of the present application have conducted extensive and in-depth research and unexpectedly discovered for the first time that in the process of preparing finerenone by reacting the compound of formula 6 with an aminating agent after being activated by an activating agent, there is no decarboxylation byproduct, the yield can be as high as 88.9%, the purity of the obtained finerenone crude product is greater than 99%, and the compound of formula 6 can be obtained by reacting 4 steps with cheap tert-butyl acetoacetate as the starting material. The yield of the compound of formula 6 obtained by splitting the intermediate compound of formula 5 is high, the ee value is high, and the splitting agent used is relatively common. On this basis, the inventors have completed the present invention.
[0107] The inventors of the present application discovered that in the process of studying the preparation method of finerenone, according to the method for preparing finerenone disclosed in the prior art, the intermediate containing an ester group is hydrolyzed to obtain the intermediate containing a carboxyl group. When the crude intermediate containing a carboxyl group is aminized, the crude finerenone obtained after the amination usually contains the same impurity (herein referred to as impurity A), and the content is relatively high. The inventors of the present application have detected the impurity A, and its mass spectrum number m / z = 336.17 [M+H] +, which is presumed to be a decarboxylation product (hereinafter referred to as impurity A), and its structure is The applicant attempted to separate and further verify the structure through H-NMR and C-NMR spectra, but the compound was unstable and ultimately the compound was not obtained.
[0108] The inventors speculate that the formation of the impurity is related to the carboxyl-containing intermediate obtained by hydrolysis. The carboxyl-containing intermediate can easily lose a proton in the reaction system and be converted into a carboxylate anion. The carboxylate anion is further removed to produce a decarboxylation byproduct. For example, in the routes 1-3 disclosed in the prior art, the carboxyl-containing intermediate obtained by hydrolyzing the ester-containing intermediate can easily remove the carboxyl group in a strong acid and strong base system (in these routes, the hydrolysis needs to be carried out in the presence of a strong base, and the system needs to be adjusted to acidity with an acid after the reaction) to generate impurity A; in the route 4 disclosed in the prior art, the carboxyl-containing intermediate is obtained by reducing the benzyl ester-containing intermediate, which removes the carboxyl group in the reduction system to generate impurity A. Because the reaction conditions are relatively mild, the content of the decarboxylation product is relatively low, but it still exists significantly.
[0109] The inventors of the present application directly subjected the crude hydrolysis product containing impurity A to an amination reaction, and the obtained finerenone product contained a relatively high content of impurity A, and its removal was relatively troublesome, increasing the preparation cost. For example, Figure 1 and Figure 3 The LC / MS spectra of the crude finerenone obtained by amination reaction of the crude hydrolyzate obtained by the routes 1 and 3 disclosed in the prior art respectively contain a large amount of impurity A. Figure 2 and Figure 4 The HPLC spectra of the crude finerenone obtained by amination reaction of the crude hydrolyzate obtained by route 2 and route 4 disclosed in the prior art respectively contain a large amount of impurity A.
[0110] In order to avoid the formation of impurity A, the inventors of the present application conducted in-depth research on the preparation method of finerenone, and unexpectedly found that by using the method of the present invention, the compound of formula 6 is activated by an activating agent and then reacted with an aminating agent, and the obtained crude finerenone product does not contain impurity A or contains a very small amount of impurity A, the post-treatment is very simple, and the final product has a high yield and purity.
[0111] Preparation method of finerenone
[0112] In a specific embodiment of the present invention, the preparation method of finerenone of the present invention comprises the following steps:
[0113] (1) a compound of formula 2 is subjected to a condensation reaction with a compound of formula 7 to produce a mixture of a compound of formula 3 and a compound of formula 3';
[0114] (2) a mixture of the compound of formula 3 and the compound of formula 3' is subjected to a condensation reaction with the compound of formula 8 to generate a compound of formula 4,
[0115] (3) In the presence of an acid, the compound of formula 4 reacts with triethyl orthoformate to produce a compound of formula 5,
[0116] (4) the compound of formula 5 is mixed with a resolving agent, subjected to a salt-forming reaction, separated to obtain a salt, and the salt is treated with a base to obtain a compound of formula 6,
[0117] (5) The compound of formula 6 is first reacted with an activating agent until the compound 6 is completely converted into an active intermediate, and an aminating agent is added to the reaction solution to allow the active intermediate to react with the aminating agent to generate finerenone.
[0118] The reaction formula is as follows:
[0119]
[0120] In step (1), the reaction of the compound of formula 2 with the compound of formula 7 can be carried out according to the conventional method of such reaction in the prior art. In some specific embodiments of the present inventors, the compound of formula 2 and the compound of formula 7 are reacted in a solvent in the presence of a base and an acid to obtain a mixture of the compound of formula 3 and the compound of formula 3'. The solvent used in the reaction includes but is not limited to dichloromethane, sec-butyl alcohol, n-butyl alcohol, isobutyl alcohol, methanol, and ethanol. The base used as a catalyst includes but is not limited to piperidine, morpholine, piperazine, and tetrahydropyrrole. The role of the acid is to activate the carbonyl group on tert-butyl acetoacetate, and the electron pair is biased to the carbon between the two carbonyl groups, making it nucleophilic, and then attacking the carbonyl group on the aldehyde to cause a condensation reaction, including but not limited to acetic acid, sulfinic acid, formic acid, butyric acid, and oxalic acid. The reaction temperature of this step is 20 to 60°C, and the reaction time is 2 to 8 hours. More preferably, the reaction temperature is 30°C to 50°C, and the reaction time is 3 to 6 hours.
[0121] In a preferred embodiment of the present invention, in step (1), the post-treatment of the mixture of the compound of formula 3 and the compound of formula 3' comprises the following steps: after the reaction is completed, the reaction solution is cooled to 10°C to 15°C, and stirred at this temperature for 6 to 20 hours, filtered to obtain a filter cake, and the filter cake is washed to obtain the compound of formula 3 which can be directly used in the next step of the reaction. The solvent used for washing is an alcohol solvent, for example, methanol or ethanol.
[0122] In step (2), the reaction of the compound of formula 3 with the compound of formula 8 to obtain the compound of formula 4 can be carried out according to the conventional method of such reaction in the prior art. The solvent used in the reaction includes but is not limited to n-butanol, isopropanol, methanol, ethanol, and sec-butanol. The reaction temperature is 50 to 120° C., and the reaction time is 10 to 24 hours. More preferably, the reaction temperature is 60 to 80° C., and the reaction time is 12 to 18 hours.
[0123] In a preferred embodiment of the present invention, in step (2), the post-treatment of the compound of formula 4 comprises the following steps: after the reaction is completed, the reaction solution is cooled to 0°C to 10°C, and stirred at this temperature for 2 to 4 hours, filtered to obtain a filter cake, and the filter cake is washed with ethyl acetate to obtain the compound of formula 4.
[0124] In step (3), the compound of formula 4 reacts with triethyl orthoformate in the presence of an acid to obtain a compound of formula 5, which can be carried out according to the conventional method of such reaction in the prior art. The acid includes but is not limited to sulfuric acid, hydrochloric acid, and phosphoric acid. The solvent used in the reaction includes but is not limited to N,N-dimethylacetamide, N,N-dimethylformamide, and N-methylpyrrolidone. The reaction temperature is a conventional temperature for carrying out such a reaction, for example, the reaction temperature is 80°C to 150°C, and the reaction time is 1 to 10 hours; more preferably, the temperature is 90°C to 140°C, and the reaction time is 3 to 6 hours.
[0125] In a preferred embodiment of the present invention, in step (3), the post-treatment of obtaining the compound of formula 5 comprises the following steps: after the reaction is completed, the reaction solution is cooled to 0°C to 40°C, water is slowly added dropwise to the system to precipitate the compound of formula 5 from the system, and a filter cake is obtained by filtering, and the filter cake is washed with water and dried to obtain the compound of formula 5.
[0126] In step (4), the compound of formula 5 is mixed with a resolving agent to form a salt, separated to obtain a salt, and the salt is treated with an alkali to obtain a compound of formula 6. The resolving agent used includes but is not limited to L-tartaric acid, L-dibenzoyltartaric acid, L-di-p-methylbenzoyltartaric acid, L-di-p-methoxybenzoyltartaric acid, L-di-p-methylbenzoyltartaric acid, L-di-p-nitrobenzoyltartaric acid, L-di-p-chlorobenzoyltartaric acid and L-di-p-cyanobenzoyltartaric acid. The salt-forming reaction is carried out in a solvent, and the solvent includes but is not limited to water, methanol, ethanol, isopropanol, n-butanol, sec-butanol, ethylene glycol dimethyl ether, acetone and ethyl acetate. The reaction temperature of the salt-forming reaction is 50-90° C. and the time is 3-12 hours; more preferably, the reaction temperature of the salt-forming reaction is 60-80° C. and the time is 5-8 hours. In a preferred embodiment of the present invention, after the salt-forming reaction is completed, the reaction system is cooled to 0-30° C. and maintained at this temperature for 5-15 hours to precipitate the formed salt, which is then filtered to obtain the salt and dried.
[0127] In a preferred embodiment of the present invention, the process of treating the salt with an alkali is as follows: adding the salt to water, dripping an aqueous solution of the alkali until the pH of the system is 7.0 to 8.0, stirring for 5 to 15 hours, and filtering to obtain the chiral compound of formula 6. In this step, the alkali used includes but is not limited to sodium hydroxide, potassium hydroxide, sodium carbonate, sodium bicarbonate and potassium carbonate.
[0128] In step (5), in the presence of a Lewis acid (as a catalyst), the compound of formula 6 is activated by an activator to obtain an activated intermediate, and the activated intermediate is then reacted with an aminating agent to obtain phenelenone. Lewis acids include but are not limited to BiCl2, TiCl4, SnCl2, AlCl3, CuCl2, MnCl2, CuI, and CuBr. The activating agent includes but is not limited to dichlorodiphenylmethane, thionyl chloride (SOCl2), oxalyl chloride (COCl)2, cyanuric chloride (TCT), chlorophosphoryl (POCl3), phosphorus trichloride (PCl3), and phosphorus pentachloride (PCl5). The aminating agent includes but is not limited to ammonia, ammonia water, an ammonia-containing organic solvent (e.g., a trifluorotoluene solution containing ammonia, a toluene solution containing ammonia, an acetonitrile solution containing ammonia), and hexamethyldisilazane. The reaction temperature for generating the activated intermediate and amination is a conventional temperature for carrying out such reactions. In some preferred embodiments of the present invention, the reaction temperature for generating the activated intermediate and the amination is 5 to 40°C, more preferably, the reaction temperature is 15 to 30°C. The solvent used in the reaction includes but is not limited to dichloroethane, 1,4-dioxane, tetrahydrofuran, acetonitrile, toluene, trifluorotoluene, and dichloromethane. In some preferred embodiments of the present invention, dichlorodiphenylmethane is used as an activating agent. In some preferred embodiments of the present invention, ammonia is used as an aminating agent, and the pressure of the ammonia atmosphere is 0.2 to 1.0 MPa, more preferably 0.3 to 0.4 MPa.
[0129] The reaction mechanism of step (5) is as follows Figure 8 As shown: Under the catalysis of SnCl2, the compound of formula 6 reacts with dichlorodiphenylmethane to form an acyl chloride intermediate, and the acyl chloride intermediate then reacts with ammonia to form finerenone.
[0130] The advantages of the method for preparing finerenone of the present invention are:
[0131] (1) In the step of preparing finerenone from the compound of formula 6, the tert-butyl ester is activated to generate an activated intermediate, and the activated intermediate is directly aminated to generate finerenone without hydrolysis to obtain carboxylic acid. The product has a high yield and high purity (greater than 99.0%), and is easy to purify without decarboxylation byproducts.
[0132] (2) The raw material tert-butyl acetoacetate used in the preparation of the compound of formula 6 is cheap and easily available, and the resolution yield of the compound of formula 6 obtained from the compound of formula 5 is high, and the resolution agents used are all conventional resolution agents.
[0133] (3) The preparation method of finerenone of the present invention has a short process, and the final product can be obtained through only 5 steps of reaction. The reaction conditions of each step are mild, the post-treatment is simple, the production is safe and reliable, no precious metal catalyst is required, there is no heavy metal residue problem, the production cost is low, and it is suitable for industrial large-scale production.
[0134] The present invention will be further described below in conjunction with specific examples. It should be understood that these examples are only intended to illustrate the present invention and are not intended to limit the scope of the present invention. The experimental methods for the unrecorded specific conditions in the following examples are usually based on normal conditions. Unless otherwise stated, percentages and parts are weight percentages and weight parts.
[0135] In the following examples, raw materials are commercially available unless otherwise specified.
[0136] Example 1 Synthesis of a mixture of the compound of formula 3 and the compound of formula 3'
[0137]
[0138] Add 1.61g (10mmol) 4-cyano-3-methoxybenzaldehyde to the reaction bottle, then add 2.37g (15mmol) tert-butyl acetoacetate, 60mg (1mmol) acetic acid, 85mg (1mmol) piperidine and 15mL isopropanol in sequence, stir evenly, heat to 40°C for 3-4 hours, TLC detection shows that almost all the raw materials react, stop the reaction, start cooling, cool down by 10-15°C, stir for 14 hours, filter, wash the filter cake with about 5ml isopropanol, dry to obtain 2.772g solid, HPLC purity 99.2%, molar yield 91.3%. MS: m / z=302[M+H] + .
[0139] Example 2-1 Synthesis of Compound of Formula 4
[0140]
[0141] Add 1.51g (4.97mmol, purity 99.2%) of a mixture of the compound of formula 3 and the compound of formula 3' and 30mL of isopropanol to the reaction bottle, then add 740mg (5.96mmol) of 4-amino-5-methylpyridin-2(1H)-one, heat to 70°C and react for 15 hours. TLC detection shows that almost all the raw materials have reacted, and the reaction is stopped. Start cooling to T = 0-10°C, stir for 2-4 hours, filter, wash the filter cake with ethyl acetate (10mL), and dry to obtain 1.829g of solid, HPLC purity 99.1%, molar yield 89.5%. MS: m / z = 408 [M+H] + .
[0142] Example 2-2 Synthesis of Compound of Formula 4
[0143] Add 1.51g (4.97mmol, purity 99.2%) of a mixture of the compound of formula 3 and the compound of formula 3' and 30mL of methanol to the reaction bottle, then add 868mg (7.00mmol) of 4-amino-5-methylpyridin-2(1H)-one, heat to 65°C and react for 18 hours. TLC shows that almost all the raw materials react, and the reaction is stopped. Start cooling to T = 0°C, stir for 2 hours, filter, wash the filter cake with ethyl acetate (10mL), and dry to obtain 1.831g of solid, HPLC purity 98.1%, molar yield 88.7%. MS: m / z = 408 [M+H] + .
[0144] Example 2-3 Synthesis of Compound of Formula 4
[0145] Add 1.51g (4.97mmol, purity 99.2%) of a mixture of the compound of formula 3 and the compound of formula 3' and 30mL of sec-butyl alcohol to the reaction bottle, then add 679mg (5.47mmol) of 4-amino-5-methylpyridin-2(1H)-one, heat to 80°C and react for 13 hours. TLC detection shows that almost all the raw materials react, and the reaction is stopped. Start cooling to 5°C, stir for 3 hours, filter, wash the filter cake with ethyl acetate (10mL), and dry to obtain 1.828g of solid, HPLC purity 98.5%, molar yield 88.9%. MS: m / z=408[M+H] + .
[0146] Example 2-4 Synthesis of Compound of Formula 4
[0147] Add 1.51g (4.97mmol, purity 99.2%) of a mixture of the compound of formula 3 and the compound of formula 3' and 30mL of ethanol to the reaction bottle, then add 925mg (7.46mmol) of 4-amino-5-methylpyridin-2(1H)-one, heat to 75°C and reflux for 15 hours. TLC shows that almost all the raw materials have reacted, and the reaction is stopped. Start cooling to 4°C, stir for 4 hours, filter, wash the filter cake with ethyl acetate (10mL), and dry to obtain 1.828g of solid, HPLC purity 98.7%, molar yield 89.1%. MS: m / z=408[M+H] + .
[0148] Example 3-1 Synthesis of Compound of Formula 5
[0149]
[0150] Add 11.2g (27.24mmol, purity 99.1%) of compound 4, 6.5g (43.58mmol) of triethyl orthoformate and 50mL of N,N-dimethylformamide to the reaction flask. After heating to 120°C, slowly drop 0.5mL (6mol / L) of sulfuric acid and react for 3 to 6 hours. After TLC detection, the reaction is complete and the reaction is stopped. Cool to room temperature and slowly drop water (100mL of water is added in 20 minutes) to precipitate the product. Filter, wash the filter cake with about 60mL of water, and dry to obtain 11.4g of powder, HPLC purity 99.2%, molar yield 95.2%. MS: m / z = 436 [M+H] + .
[0151] Example 3-2 Synthesis of Compound of Formula 5
[0152] Add 11.2g (27.24mmol, purity 99.1%) of compound 4, 8.07g (54.48mmol) of triethyl orthoformate and 55mL of N,N-dimethylacetamide to the reaction flask. After heating to 100°C, slowly add 0.3mL of concentrated hydrochloric acid and react for 3 to 6 hours. After TLC detection, the reaction is complete and the reaction is stopped. Cool to room temperature and slowly add water (110mL of water is added in 20 minutes) to precipitate the product. Filter and wash the filter cake with about 60mL of water and dry to obtain 11.160g of powder. HPLC purity is 99.1% and the molar yield is 93.4%. MS: m / z=436[M+H] + .
[0153] Example 3-3 Synthesis of Compound of Formula 5
[0154] Add 11.2g (27.24mmol, purity 99.1%) of compound 4, 10.1g (68.10mmol) of triethyl orthoformate and 50mL of N-methylpyrrolidone to the reaction flask. After heating to 130°C, slowly drop 0.5mL (6mol / L) of sulfuric acid and react for 3 to 6 hours. After TLC detection, the reaction is complete and the reaction is stopped. Cool to room temperature and slowly drop water (120mL of water is added in 25 minutes) to precipitate the product. Filter, wash the filter cake with about 60mL of water, and dry to obtain 11.156g of powder, HPLC purity 98.5%, molar yield 92.8%. MS: m / z=436[M+H] + .
[0155] Example 4-1 Synthesis of Compound 6
[0156]
[0157] Add 4.36g (9.94mmol, purity 99.2%) of compound 5, 2.36g (6.58mmol) of L-dibenzoyltartaric acid, 300mL of methanol to the reaction bottle, and heat to 70°C for 6 hours. After the reaction is completed by TLC detection, the reaction solution is naturally cooled to room temperature, crystallized overnight, and dried to obtain the split salt. Add the split salt to the bottle, add 250mL of water, drop saturated sodium bicarbonate to pH = 8-9, stir overnight, filter, and dry to obtain 2.104g of compound 6. HPLC purity 99.1%, ee value 99.8%, molar yield 48.2%.
[0158] Example 4-2 Synthesis of Compound 6
[0159] Add 4.36g (9.94mmol, purity 99.2%) of compound 5, 3.33g (7.95mmol) of L-di-p-methoxybenzoyltartaric acid, and 300mL of ethanol to the reaction bottle, and heat to 60°C for 6 hours. After the reaction is completed by TLC detection, the reaction solution is naturally cooled to room temperature, crystallized overnight, and dried to obtain the split salt. The split salt is added to the bottle, 250mL of water is added, saturated sodium bicarbonate is added dropwise to pH = 8 to 9, stirred overnight, filtered, and dried to obtain 2.084g of compound 6. HPLC purity 98.0%, ee value 99.7%, molar yield 47.2%.
[0160] Example 4-3 Synthesis of Compound of Formula 6
[0161] Add 4.36g (9.94mmol, purity 99.2%) of compound 5, 2.69g (6.96mmol) of L-di-p-methylbenzoyltartaric acid, 300mL of isopropanol to the reaction bottle, and heat to 60°C for 6 hours. After the reaction is completed by TLC detection, the reaction solution is naturally cooled to room temperature, crystallized overnight, and dried to obtain the split salt. The split salt is added to the bottle, 250mL of water is added, saturated sodium phosphate is added dropwise to pH = 8 to 9, stirred overnight, filtered, and dried to obtain 2.117g of compound 6. HPLC purity 98.5%, ee value 99.4%, molar yield 47.9%.
[0162] Example 4-4 Synthesis of Compound of Formula 6
[0163] Add 4.36g (9.94mmol, purity 99.2%) of Formula 5 compound, 2.55g (5.97mmol) of L-di-p-chlorobenzoyltartaric acid, 300mL of acetone to the reaction bottle, and heat to 60°C, react for 6 hours, after the reaction is completed by TLC detection, the reaction solution is naturally cooled to room temperature, crystallized overnight, and dried to obtain the split salt. The split salt is added to the bottle, 250mL of water is added, saturated sodium bicarbonate is added dropwise to pH = 8 to 9, stirred overnight, filtered, and dried to obtain 2.099g of Formula 6 compound. HPLC purity 99.1%, ee value 98.2%, molar yield 47.2%.
[0164] Example 4-5 Synthesis of Compound of Formula 6
[0165] Add 4.36g (9.94mmol, purity 99.2%) of compound 5, 2.84g (6.96mmol) of L-di-p-cyanobenzoyltartaric acid, 300mL of ethyl acetate to the reaction bottle, and heat to 60°C for 6 hours. After the reaction is completed by TLC detection, the reaction solution is naturally cooled to room temperature, crystallized overnight, and dried to obtain the split salt. The split salt is added to the bottle, 250mL of water is added, saturated sodium bicarbonate is added dropwise to pH = 8 to 9, stirred overnight, filtered, and dried to obtain 2.091g of compound 6. HPLC purity 98.5%, ee value 99.4%, molar yield 47.6%.
[0166] Example 4-6 Synthesis of Compound of Formula 6
[0167] Add 4.36g (9.94mmol, purity 99.2%) of Formula 5 compound, 2.54g (6.58mmol) of L-di-p-methylbenzoyltartaric acid, 300mL of dichloromethane to the reaction bottle, and heat to 60°C for 6 hours. After the reaction is completed by TLC detection, the reaction solution is naturally cooled to room temperature, crystallized overnight, and dried to obtain the split salt. The split salt is added to the bottle, 250mL of water is added, saturated sodium bicarbonate is added dropwise to pH = 8 to 9, stirred overnight, filtered, and dried to obtain 2.082g of Formula 6 compound. HPLC purity 98.6%, ee value 99.3%, molar yield 47.4%.
[0168] Example 4-7 Synthesis of Compound 6
[0169] Add 4.36g (9.94mmol, purity 99.2%) of Formula 5 compound, 2.36g (6.58mmol) of L-dibenzoyltartaric acid, 300mL of n-butanol to the reaction bottle, and heat to 60°C, react for 6 hours, after the reaction is completed by TLC detection, the reaction solution is naturally cooled to room temperature, crystallized overnight, and dried to obtain the split salt. The split salt is added to the bottle, 250mL of water is added, saturated sodium bicarbonate is added dropwise to pH = 8 to 9, stirred overnight, filtered, and dried to obtain 2.083g of Formula 6 compound. HPLC purity 98.9%, ee value 99.4%, molar yield 47.6%.
[0170] Example 4-8 Synthesis of Compound of Formula 6
[0171] Add 4.36g (9.94mmol, purity 99.2%) of Formula 5 compound, 2.75g (6.58mmol) of L-di-p-methoxybenzoyltartaric acid, 300mL of sec-butyl alcohol to the reaction bottle, and heat to 60°C, react for 6 hours, after the reaction is completed by TLC detection, the reaction solution is naturally cooled to room temperature, crystallized overnight, and dried to obtain the split salt. The split salt is added to the bottle, 250mL of water is added, saturated sodium bicarbonate is added dropwise to pH = 8-9, stirred overnight, filtered, and dried to obtain 2.071g of Formula 6 compound.
[0172] HPLC purity: 98.4%, ee value: 99.3%, molar yield: 47.1%.
[0173] Example 4-9 Synthesis of Compound of Formula 6
[0174] Add 4.36g (9.94mmol, purity 99.2%) of compound 5, 0.987g (6.58mmol) of L-tartaric acid, 300mL of sec-butanol to the reaction bottle, and heat to 60°C for 6 hours. After the reaction is completed by TLC detection, the reaction solution is naturally cooled to room temperature, crystallized overnight, and dried to obtain the split salt. Add the split salt to the bottle, add 250mL of water, drop saturated sodium bicarbonate to pH = 8-9, stir overnight, filter, and dry to obtain 2.067g of compound 6. HPLC purity 98.2%, ee value 99.4%, molar yield 46.9%.
[0175] Example 5-1 Synthesis of Finerenone
[0176]
[0177] At room temperature (about 20°C), dichlorodiphenylmethane (0.283g, 1.20mmol), compound 6 (0.378g, 0.86mmol, purity 99.1%), SnCl2 (0.00379g, 0.02mmol) and 2mL dichloroethane (DCE) were added to the reactor. After reacting for 3 hours, N,N-diisopropylethylamine (0.194g, 1.50mmol) was added, and NH3 gas was passed until the pressure in the autoclave was 0.2-0.3Mpa. The reaction was continued for 30 minutes. After the reaction was detected by TLC, the organic matter was extracted with a mixture of CH2Cl2 and water (2×30mL, the volume ratio of CH2Cl2 and water was 1:5). The organic layer was dried over anhydrous sodium sulfate and concentrated, and dried to obtain 0.291g of phenerenone. HPLC purity 99.6% (see Figure 5 ), ee value 99.5%, molar yield 89.1%. Figure 5 The HPLC spectrum showed that the content of decarboxylation byproducts was very small (RT = 16.215 min).
[0178] The finerenone was added to 8 mL of ethanol, heated to reflux, the solvent was evaporated to 2 mL, and then the temperature was slowly lowered to 0°C, and stirred at 0°C for 5 h, filtered and separated, and vacuum dried at 40°C for 16 h to obtain 0.28 g of a white solid (without impurity A), the HPLC purity of which was 99.96% (see Figure 6 ).
[0179] MS: m / z = 379 [M+H] + .
[0180] 1 H NMR (400MHz, DMSO-d6): δ=7.68(s,1H), 7.55(s,1H), 7.37(s,H), 7.27~7.29(dd,1H), 7.15(d,1H), 6. 76(d,2H), 5.39(s,1H), 3.96(m,2H), 3.82~4.06(s,3H), 2.18(s,3H), 2.12(s,3H), 1.07~1.04(t,3H). 13 C NMR (125MHz, DMSO-d6): δ=170.16, 159.85, 156.16, 144.69, 144.65, 142.16, 138.57, 131.36, 125 .22, 119.43, 114.62, 111.90, 109.98, 105.83, 103.65, 60.99, 56.53, 32.90, 18.52, 14.75, 14.20. MS: m / z=379[M+H] + .
[0181] Example 5-2 Synthesis of Finerenone
[0182] At room temperature (about 20°C), dichlorodiphenylmethane (0.247g, 1.03mmol), compound 6 (0.378g, 0.86mmol, purity 99.1%), BiCl2 (0.00946g, 0.03mmol) and 2mL dichloromethane were added to the reaction kettle. After reacting for 3 hours, N,N-diisopropylethylamine (0.194g, 1.50mmol) was added, and NH3 gas was passed until the pressure in the autoclave was 0.3-0.4Mpa. The reaction was continued for 30 minutes. After the reaction was detected by TLC, the organic matter was extracted with a mixture of CH2Cl2 and water (2×30mL, the volume ratio of CH2Cl2 and water was 1:5). The organic layer was dried over anhydrous sodium sulfate and concentrated, and dried to obtain 0.284g phenerenone (without impurity A). HPLC purity 99.8% (see Figure 7 ), ee value 99.3%, molar yield 87.1%. MS: m / z = 379 [M+H] + . Figure 7 The HPLC profile of the product showed no decarboxylation byproducts.
[0183] Example 5-3 Synthesis of Finerenone
[0184] At room temperature (about 20°C), dichlorodiphenylmethane (0.265g, 1.12mmol), compound 6 (0.378g, 0.86mmol, purity 99.1%), SnCl2 (0.00379g, 0.02mmol) and 2mL 1,4-dioxane were added to the reaction bottle. After 3 hours of reaction, N,N-diisopropylethylamine (0.194g, 1.50mmol) and 2mL ammonia water (mass concentration of 10%) were added. The reaction was continued for 30 minutes. After the reaction was completed by TLC detection, the organic matter was extracted with a mixed solution of CH2Cl2 and water (2×30mL, the volume ratio of CH2Cl2 and water was 1:5). The organic layer was dried over anhydrous sodium sulfate and concentrated, and dried to obtain 0.270g phenerenone (without impurity A). HPLC purity 99.5%, ee value 99.2%, molar yield 82.5%. MS: m / z = 379 [M+H] + .
[0185] Example 5-4 Synthesis of Finerenone
[0186] At room temperature (about 20°C), dichlorodiphenylmethane (0.283g, 1.20mmol), compound 6 (0.378g, 0.860mmol, purity 99.1%), AlCl3 (0.008g, 0.06mmol) and 2mL tetrahydrofuran were added to the reaction bottle. After reacting for 3 hours, triethylamine (0.174g, 1.72mmol) and 2mL ammonia water (mass concentration of 10%) were added and reacted for 30 minutes. After the reaction was completed by TLC detection, the organic matter was extracted with a mixed solution of CH2Cl2 and water (2×30mL, the volume ratio of CH2Cl2 and water was 1:5). The organic layer was dried over anhydrous sodium sulfate and concentrated, and dried to obtain 0.267g phenerenone (without impurity A). HPLC purity 99.3%, ee value 99.1%, molar yield 81.5%. MS: m / z=379[M+H] + .
[0187] Example 5-5 Synthesis of Finerenone
[0188] At room temperature (about 20°C), dichlorodiphenylmethane (0.283g, 1.20mmol), compound 6 (0.378g, 0.860mmol, purity 99.1%), SnCl2 (0.00379g, 0.02mmol) and 2mL acetonitrile were added to the reaction bottle. After reacting for 3 hours, N,N-diisopropylethylamine (0.194g, 1.50mmol) and 4mL acetonitrile solution containing NH3 (mass concentration of 10%) were added, and the reaction was continued for 30 minutes. After the reaction was completed by TLC detection, the organic matter was extracted with a mixed solution of CH2Cl2 and water (2×30mL, the volume ratio of CH2Cl2 and water was 1:5), and the organic layer was dried over anhydrous sodium sulfate and concentrated, and dried to obtain 0.270g phenerenone (without impurity A). HPLC purity 99.4%, ee value 99.2%, molar yield 82.5%. MS: m / z = 379 [M+H] + .
[0189] Example 5-6 Synthesis of Finerenone
[0190] At room temperature (about 20°C), dichlorodiphenylmethane (0.283g, 1.20mmol), compound 6 (0.378g, 0.860mmol, purity 99.1%), MnCl2 (0.00252g, 0.02mmol) and 2mL toluene were added to the reaction bottle. After reacting for 3 hours, pyridine (0.17g, 2.15mmol) and 4mL toluene solution containing NH3 (mass concentration of 10%) were added, and the reaction was continued for 30 minutes. After the reaction was completed by TLC detection, the organic matter was extracted with a mixed solution of CH2Cl2 and water (2×30mL, the volume ratio of CH2Cl2 and water was 1:5). The organic layer was dried over anhydrous sodium sulfate and concentrated, and dried to obtain 0.268g phenerenone (without impurity A). HPLC purity 99.4%, ee value 99.3%, molar yield 81.9%. MS: m / z=379[M+H] + .
[0191] Example 5-7 Synthesis of Finerenone
[0192] At room temperature (about 20°C), dichlorodiphenylmethane (0.283g, 1.20mmol), compound 6 (0.378g, 0.860mmol, purity 99.1%), CuCl2 (0.00403g, 0.03mmol) and 2mL trifluorotoluene were added to the reaction bottle. After reacting for 3 hours, N,N-diisopropylethylamine (0.222g, 1.72mmol) and 4mL trifluorotoluene solution containing NH3 (mass concentration of 10%) were added. The reaction was continued for 30 minutes. After the reaction was completed by TLC detection, the organic matter was extracted with a mixed solution of CH2Cl2 and water (2×30mL, the volume ratio of CH2Cl2 and water was 1:5). The organic layer was dried over anhydrous sodium sulfate and concentrated, and dried to obtain 0.267g phenerenone (without impurity A). HPLC purity 99.4%, ee value 99.2%, molar yield 81.5%. MS: m / z = 379 [M+H] + .
[0193] Example 5-8 Synthesis of Finerenone
[0194] At room temperature (about 20°C), dichlorodiphenylmethane (0.283g, 1.20mmol), compound 6 (0.378g, 0.860mmol, purity 99.1%), CuBr (0.00287g, 0.02mmol) and 2mL dichloroethane (DCE) were added to the reaction bottle. After reacting for 3 hours, N-methylmorpholine (0.191g, 1.89mmol) and 6mL of dichloroethane solution containing NH3 (mass concentration of 5%) were added. The reaction was continued for 30 minutes. After the reaction was completed, the organic matter was extracted with a mixed solution of CH2Cl2 and water (2×30mL, the volume ratio of CH2Cl2 and water was 1:5). The organic layer was dried over anhydrous sodium sulfate and concentrated, and dried to obtain 0.269g of phenerenone. HPLC purity 99.4% (without impurity A), ee value 99.1%, molar yield 82.2%.
[0195] Example 5-9 Synthesis of Finerenone
[0196] At room temperature (about 20°C), dichlorodiphenylmethane (0.283g, 1.20mmol), compound 6 (0.378g, 0.860mmol, purity 99.1%), SnCl2 (0.00379g, 0.02mmol) and 2mL dichloroethane (DCE) were added to the reaction bottle. After reacting for 3 hours, N,N-diisopropylethylamine (0.222g, 1.72mmol) and hexamethyldisilazane (0.3228g, 2mmol) were added and reacted for 30 minutes. After the reaction was completed, the organic matter was extracted with a mixed solution of CH2Cl2 and water (2×30mL, the volume ratio of CH2Cl2 and water was 1:5), and the organic layer was dried over anhydrous sodium sulfate and concentrated, and dried to obtain 0.262g of phenerenone (without impurity A). HPLC purity 98.9%, ee value 99.1%, molar yield 79.5%.
[0197] Some of the reaction raw materials and product information of the above Examples 5-1 to 5-9 are shown in Table 1 below.
[0198] Table 1.
[0199]
[0200] As can be seen from Table 1, ammonia gas, ammonia water or ammonia organic solvents such as acetonitrile and hexamethyldisilazane that can provide amine groups can all be used in the present invention, among which ammonia gas is the most ideal as aminating agent.
[0201] All documents mentioned in the present invention are cited as references in this application, just as each document is cited as reference individually. In addition, it should be understood that after reading the above teachings of the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms also fall within the scope defined by the claims attached to this application.
Claims
1. A method for preparing finerenone, characterized in that: The preparation method comprises the following steps: (a) reacting a compound of formula 6 with an activating agent until compound 6 is completely converted into an active intermediate; (b) adding an aminating agent to the reaction solution of step (a) to react the active intermediate with the aminating agent to generate finerenone, The reaction formula is as follows: The activator is selected from dichlorodiphenylmethane, thionyl chloride, oxalyl chloride, cyanuric chloride, chlorophosphoryl, phosphorus trichloride, phosphorus pentachloride, or a combination thereof, and The aminating agent is selected from ammonia gas, ammonia water, an organic solution containing ammonia gas or hexamethyldisilazane.
2. The method for preparing finerenone according to claim 1, characterized in that: In step (a), the reaction of the compound of formula 6 with the activator is carried out in the presence of a Lewis acid, wherein the Lewis acid is selected from BiCl2, TiCl4, SnCl2, AlCl3, CuCl2, MnCl2, CuI, CuBr or a combination thereof, and / or In step (b), the reaction of the active intermediate with the aminating agent is carried out in the presence of a base, and the base is selected from triethylamine, diisopropylethylamine, pyridine, N-methylmorpholine, or a combination thereof.
3. The method for preparing finerenone according to claim 2, characterized in that: The activator is selected from dichlorodiphenylmethane, and / or The Lewis acid is selected from SnCl2 or BiCl2, and / or The aminating agent is selected from ammonia gas, ammonia water or an organic solution containing ammonia gas, and most preferably, ammonia gas.
4. The method for preparing finerenone according to claim 1 or 2, characterized in that: The preparation method of the compound of formula 6 comprises the following steps: The compound of formula 5 is mixed with a resolving agent, subjected to a salt-forming reaction, separated to obtain a salt, and the salt is treated with a base to obtain a compound of formula 6, and the reaction formula is as follows: Preferably, the resolving agent is selected from L-tartaric acid, L-dibenzoyltartaric acid, L-di-p-methylbenzoyltartaric acid, L-di-p-methoxybenzoyltartaric acid, L-dibenzoyltartaric acid, L-di-p-methoxybenzoyltartaric acid, L-di-p-methylbenzoyltartaric acid, L-di-p-nitrobenzoyltartaric acid, L-di-p-chlorobenzoyltartaric acid, L-di-p-cyanobenzoyltartaric acid, or a combination thereof, more preferably, L-dibenzoyltartaric acid, L-di-p-methylbenzoyltartaric acid.
5. The method for preparing finerenone according to claim 4, characterized in that: The preparation method of the compound of formula 5 comprises the following steps: In the presence of an acid, the compound of formula 4 reacts with triethyl orthoformate to generate a compound of formula 5. The reaction formula is as follows: Preferably, the acid is selected from sulfuric acid, hydrochloric acid, nitric acid, phosphoric acid, or a combination thereof.
6. The method for preparing finerenone according to claim 5, characterized in that: The preparation method of the compound of formula 4 comprises the following steps: (1) a compound of formula 2 is subjected to a condensation reaction with a compound of formula 7 to produce a mixture of a compound of formula 3 and a compound of formula 3'; (2) a mixture of the compound of formula 3 and the compound of formula 3' is subjected to a condensation reaction with the compound of formula 8 to generate a compound of formula 4, The reaction formula is as follows:
7. A method for preparing finerenone, characterized in that: The preparation method comprises the following steps: (1) a compound of formula 2 is subjected to a condensation reaction with a compound of formula 7 to produce a mixture of a compound of formula 3 and a compound of formula 3'; (2) a mixture of the compound of formula 3 and the compound of formula 3' is subjected to a condensation reaction with the compound of formula 8 to generate a compound of formula 4, (3) In the presence of an acid, the compound of formula 4 reacts with triethyl orthoformate to produce a compound of formula 5, (4) the compound of formula 5 is mixed with a resolving agent, subjected to a salt-forming reaction, separated to obtain a salt, and the salt is treated with a base to obtain a compound of formula 6, Wherein, the resolving agent is selected from L-tartaric acid, L-dibenzoyltartaric acid, L-di-p-methylbenzoyltartaric acid, L-di-p-methoxybenzoyltartaric acid, L-dibenzoyltartaric acid, L-di-p-methoxybenzoyltartaric acid, L-di-p-methylbenzoyltartaric acid, L-di-p-nitrobenzoyltartaric acid, L-di-p-chlorobenzoyltartaric acid, L-di-p-cyanobenzoyltartaric acid, or a combination thereof, (5) The compound of formula 6 is first reacted with an activating agent until the compound 6 is completely converted into an active intermediate, and an aminating agent is added to the reaction solution to allow the active intermediate to react with the aminating agent to generate finerenone. Wherein, the activator is selected from dichlorodiphenylmethane, thionyl chloride, oxalyl chloride, cyanuric chloride, chlorophosphoryl, phosphorus trichloride, phosphorus pentachloride, or a combination thereof, and Wherein, the aminating agent is selected from ammonia gas, ammonia water, an organic solution containing ammonia gas or hexamethyldisilazane, The reaction formula is as follows:
8. A method for preparing a compound of formula 4, characterized in that: The preparation method comprises the following steps: (1) a compound of formula 2 is subjected to a condensation reaction with a compound of formula 7 to produce a mixture of a compound of formula 3 and a compound of formula 3'; (2) a mixture of the compound of formula 3 and the compound of formula 3' is subjected to a condensation reaction with the compound of formula 8 to generate a compound of formula 4, 9. A method for preparing a compound of formula 5, characterized in that: The following steps are involved: (3-1) providing a compound of formula 4, preferably, the compound of formula 4 is obtained according to the preparation method of claim 8, (3-2) In the presence of an acid, the compound of formula 4 reacts with triethyl orthoformate to generate a compound of formula 5, The reaction formula is as follows:
10. A method for preparing a compound of formula 6, characterized in that: The preparation method comprises the following steps: (4-1) providing a compound of formula 5, preferably, the compound of formula 5 is obtained according to the preparation method of claim 9, (4-2) The compound of formula 5 is mixed with a resolving agent, subjected to a salt-forming reaction, separated to obtain a salt, and the salt is treated with a base to obtain a compound of formula 6. The reaction formula is as follows: Preferably, the resolving agent is selected from L-tartaric acid, L-dibenzoyltartaric acid, L-di-p-methylbenzoyltartaric acid, L-di-p-methoxybenzoyltartaric acid, L-dibenzoyltartaric acid, L-di-p-methoxybenzoyltartaric acid, L-di-p-methylbenzoyltartaric acid, L-di-p-nitrobenzoyltartaric acid, L-di-p-chlorobenzoyltartaric acid, L-di-p-cyanobenzoyltartaric acid, or a combination thereof, more preferably, L-dibenzoyltartaric acid, L-di-p-methylbenzoyltartaric acid.
11. A compound, the structure of which is shown below:
Citation Information
Patent Citations
Substituted 4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof
CN101641352A
Method for preparing fenerenone and intermediates thereof
CN115340539A
Technological preparation method of fenerenone
CN116496273A
Preparation method of fenerenone bulk drug
CN116891471A
Preparation method of fenerenone and key chiral intermediate of fenerenone
CN116023377A
